These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 24382352)

  • 1. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.
    Xue J; Lin X; Chiu WT; Chen YH; Yu G; Liu M; Feng XH; Sawaya R; Medema RH; Hung MC; Huang S
    J Clin Invest; 2014 Feb; 124(2):564-79. PubMed ID: 24382352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Tong X; Wang S; Lei Z; Li C; Zhang C; Su Z; Liu X; Zhao J; Zhang HT
    Oncogene; 2020 Apr; 39(14):2890-2904. PubMed ID: 32029901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.
    Chan DW; Hui WW; Wang JJ; Yung MM; Hui LM; Qin Y; Liang RR; Leung TH; Xu D; Chan KK; Yao KM; Tsang BK; Ngan HY
    Oncogene; 2017 Mar; 36(10):1404-1416. PubMed ID: 27593933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.
    Levy L; Howell M; Das D; Harkin S; Episkopou V; Hill CS
    Mol Cell Biol; 2007 Sep; 27(17):6068-83. PubMed ID: 17591695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
    Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
    Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
    Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
    J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity.
    Li X; Thyssen G; Beliakoff J; Sun Z
    J Biol Chem; 2006 Aug; 281(33):23748-56. PubMed ID: 16777850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 interacts with Smad3 and regulates Smad3-mediated TGF-beta signaling during oxidative stress responses.
    Li H; Sekine M; Seng S; Avraham S; Avraham HK
    PLoS One; 2009 Sep; 4(9):e7091. PubMed ID: 19768112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
    Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
    Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
    Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
    Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition.
    Vincent T; Neve EP; Johnson JR; Kukalev A; Rojo F; Albanell J; Pietras K; Virtanen I; Philipson L; Leopold PL; Crystal RG; de Herreros AG; Moustakas A; Pettersson RF; Fuxe J
    Nat Cell Biol; 2009 Aug; 11(8):943-50. PubMed ID: 19597490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of TGF-β signaling at the nuclear envelope: characterization of interactions between MAN1, Smad2 and Smad3, and PPM1A.
    Bourgeois B; Gilquin B; Tellier-Lebègue C; Östlund C; Wu W; Pérez J; El Hage P; Lallemand F; Worman HJ; Zinn-Justin S
    Sci Signal; 2013 Jun; 6(280):ra49. PubMed ID: 23779087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
    Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
    J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.
    Bryson BL; Junk DJ; Cipriano R; Jackson MW
    Cell Cycle; 2017 Feb; 16(4):319-334. PubMed ID: 27892764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
    Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
    Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
    Yuki R
    Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Smad3 and TTF-1/NKX2-1 complex regulates Smad4-independent gene expression.
    Isogaya K; Koinuma D; Tsutsumi S; Saito RA; Miyazawa K; Aburatani H; Miyazono K
    Cell Res; 2014 Aug; 24(8):994-1008. PubMed ID: 25060702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
    Pierreux CE; Nicolás FJ; Hill CS
    Mol Cell Biol; 2000 Dec; 20(23):9041-54. PubMed ID: 11074002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELL Protein-associated Factor 2 (EAF2) Inhibits Transforming Growth Factor β Signaling through a Direct Interaction with Smad3.
    Liu X; Chen Z; Ouyang G; Song T; Liang H; Liu W; Xiao W
    J Biol Chem; 2015 Oct; 290(43):25933-45. PubMed ID: 26370086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition.
    Reka AK; Kurapati H; Narala VR; Bommer G; Chen J; Standiford TJ; Keshamouni VG
    Mol Cancer Ther; 2010 Dec; 9(12):3221-32. PubMed ID: 21159608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.